Columbia Care's March quarter result has been released. (Seems like a good partner to have in the U.S.) Highlights include:
-45% higher revenue of $U.S. 12.9 million in Q1, 2019 from growth in existing jurisdictions and higher consumer demand. -Gross profit up 29% YOY to $U.S. 4.4 million -Cash position of $U.S. 169.6 million, zero debt, following recent listing -It has launched a new hemp-based CBD line in the new quarter -Plans to expedite the commercialization of these brands into traditional consumer retail channels -Acceleration of its expansion of operations as a result of public status